Continuous Versus Intermittent Infusion of Vancomycin and the Risk of Acute Kidney Injury in Critically Ill Adults: A Systematic Review and Meta-Analysis*
- 20 April 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 48 (6) , 912-918
Abstract
Objectives: Critically ill patients routinely receive vancomycin as empiric antibiotic therapy. A continuous infusion administration strategy may be superior to intermittent infusion by minimizing peak concentrations and variability thereby optimizing safety. We performed a systematic review and meta-analysis to investigate the impact of vancomycin infusion strategy on acute kidney injury in critically ill adults. Data Sources: A systematic search of MEDLINE, CINAHL, Web of Science, International Pharmaceutical Abstracts, and Google Scholar was undertaken. Study Selection: We included randomized controlled trials and observational studies evaluating acute kidney injury in critically ill adults comparing vancomycin administered by intermittent and continuous infusion. Secondary outcomes included mortality and pharmacokinetic target attainment. Data Extraction: Eleven studies were identified for analysis with baseline demographics, endpoints, protocol definitions, and outcomes extracted. Data Synthesis: When compared with intermittent infusion, continuous infusion was associated with a reduction in acute kidney injury in critically ill adults (odds ratio, 0.47; 95% CI, 0.34–0.65) and a 2.6 greater odds of pharmacokinetic target attainment (odds ratio, 2.63; 95% CI, 1.52–4.57). No difference in mortality was observed (odds ratio, 1.04; 95% CI, 0.80–1.35). Conclusions: When administered via a continuous infusion, vancomycin is associated with a 53% reduction in the odds of acute kidney injury and a 2.6-fold higher odds of pharmacokinetic target attainment when compared with intermittent infusion without influencing overall mortality.Keywords
This publication has 29 references indexed in Scilit:
- Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessmentsBMC Medical Research Methodology, 2014
- Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?Antimicrobial Agents and Chemotherapy, 2014
- Serum Vancomycin Levels Resulting From Continuous or Intermittent Infusion in Critically Ill Burn Patients With or Without Continuous Renal Replacement TherapyJournal of Burn Care & Research, 2012
- Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2011
- Influence of Vancomycin on Renal Function in Critically Ill Patients after Cardiac SurgeryAnesthesiology, 2009
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAmerican Journal of Health-System Pharmacy, 2009
- A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpointsStatistics in Medicine, 2005
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized StudyAntimicrobial Agents and Chemotherapy, 2001
- Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infectionsJournal of Antimicrobial Chemotherapy, 1995